Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

Figure 2

(a) Receiver operating characteristic curves for predicting 6-month and 12-month PFS by the neutrophil-to-lymphocyte ratio (AUC areas under the curve are 0.71 and 0.66). (b) AUC value by PFS time.

(a)

(b)